Valeant Pharmaceuticals International (VRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
30-Sep-10 8:37 PM
View: 
Koppes Richard
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 54,523----(100%)
54.52K to 0
20-Oct-10 5:52 PM
View: 
Karlson Elisa A.
EVP, Chief Admin Officer
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 218,663----(100%)
218.66K to 0
30-Sep-10 8:35 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 60,627----(100%)
60.63K to 0
20-Oct-10 5:59 PM
View: 
Blott Peter J
EVP, Chief Financial Officer
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 216,889----(100%)
216.89K to 0
30-Sep-10 8:39 PM
View: 
Provencio Norma Ann
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 39,574----(100%)
39.57K to 0
20-Oct-10 6:00 PM
View: 
de Silva Rajiv
Chief Operating Officer
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 261,994----(100%)
261.99K to 0
30-Sep-10 8:34 PM
View: 
Stefano Stephen F.
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 10,902----(100%)
10.9K to 0
30-Sep-10 8:34 PM
View: 
Lonner Anders
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 12,766----(100%)
12.77K to 0
30-Sep-10 8:53 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 15,163,000----(100%)
15.16M to 0
20-Oct-10 5:55 PM
View: 
Pearson J. Michael
CEO and Chairman
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 1,931,500----(100%)
1.93M to 0
30-Sep-10 8:36 PM
View: 
Ingram Robert Alexander
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 79,053----(100%)
79.05K to 0
20-Oct-10 5:56 PM
View: 
Min Steve T.
EVP, General Counsel
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 213,069----(100%)
213.07K to 0
30-Sep-10 8:40 PM
View: 
Kugelman Larry
Director
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 55,589----(100%)
55.59K to 0
20-Oct-10 5:49 PM
View: 
Chaudhuri Bhaskar
President
Valeant Pharmaceuticals Int... (VRX) 28-Sep-10Disposition 333,438----(100%)
333.44K to 0
24-Aug-10 7:29 PM
View: 
de Silva Rajiv
Chief Operating Officer
Valeant Pharmaceuticals Int... (VRX) 24-Aug-10Payment of Exercise 2,387$57.02$136,107.00(2%)
96.49K to 94.1K
(< 1%)
06-Jul-10 7:48 PM
View: 
Provencio Norma Ann
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 406----< 1%
45.21K to 45.62K
06-Jul-10 7:48 PM
View: 
Lonner Anders
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 320----3%
12.45K to 12.77K
06-Jul-10 7:48 PM
View: 
Stefano Stephen F.
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 135----< 1%
19.57K to 19.71K
06-Jul-10 7:46 PM
View: 
Ingram Robert Alexander
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 345----< 1%
42.52K to 42.86K
06-Jul-10 7:47 PM
View: 
Kugelman Larry
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 357----< 1%
37.25K to 37.61K
06-Jul-10 7:47 PM
View: 
Koppes Richard
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 153----< 1%
30.39K to 30.54K
06-Jul-10 7:48 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Jul-10Grant 369----< 1%
47.28K to 47.65K
01-Jul-10 7:52 PM
View: 
Min Steve T.
EVP and General Counsel
Valeant Pharmaceuticals Int... (VRX) 30-Jun-10Payment of Exercise 1,037$52.29$54,224.70(2%)
60.95K to 59.91K
< 1%
11-Jun-10 5:57 PM
View: 
de Silva Rajiv
Chief Operating Officer
Valeant Pharmaceuticals Int... (VRX) 09-Jun-10Market Option Sale 23,000$45.24$1,040,570.00(19%)
119.49K to 96.49K
(1%)
11-Jun-10 5:57 PM
View: 
de Silva Rajiv
Chief Operating Officer
Valeant Pharmaceuticals Int... (VRX) 09-Jun-10Option Exercise 23,000$22.68$521,640.0024%
96.49K to 119.49K
13-May-10 1:02 PM
View: 
Ingram Robert Alexander
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 3,500----9%
39.02K to 42.52K
13-May-10 1:03 PM
View: 
Kugelman Larry
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----8%
34.57K to 37.25K
13-May-10 1:03 PM
View: 
Koppes Richard
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----10%
27.71K to 30.39K
13-May-10 1:04 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----6%
44.6K to 47.28K
13-May-10 2:27 PM
View: 
Morfit G Mason
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----12%
22.01K to 24.69K
13-May-10 1:04 PM
View: 
Provencio Norma Ann
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----6%
42.53K to 45.21K
13-May-10 1:03 PM
View: 
Lonner Anders
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----27%
9.77K to 12.45K
13-May-10 1:05 PM
View: 
Stefano Stephen F.
Director
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant 2,677----16%
16.89K to 19.57K
13-May-10 2:44 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 11-May-10Grant
Duplicate
2,677----< 1%
15.16M to 15.16M
04-May-10 2:37 PM
View: 
Valueact Holdings, L.P.
10% Owner
Valeant Pharmaceuticals Int... (VRX) 30-Apr-10Market Sale 2,637,540$40.41$106,583,000.00(15%)
17.78M to 15.14M
(17%)
07-Apr-10 7:02 PM
View: 
Karlson Elisa A.
EVP & Chief Administrative
Valeant Pharmaceuticals Int... (VRX) 07-Apr-10Payment of Exercise 1,635$44.05$72,021.80(2%)
84.14K to 82.5K
(< 1%)
05-Apr-10 7:12 PM
View: 
Koppes Richard
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 180----< 1%
27.53K to 27.71K
05-Apr-10 7:12 PM
View: 
Melas Kyriazi Theo
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 434----< 1%
44.17K to 44.6K
05-Apr-10 7:13 PM
View: 
Provencio Norma Ann
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 476----1%
42.06K to 42.53K
05-Apr-10 7:12 PM
View: 
Lonner Anders
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 376----4%
9.39K to 9.77K
05-Apr-10 7:13 PM
View: 
Stefano Stephen F.
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 201----1%
16.69K to 16.89K
05-Apr-10 7:11 PM
View: 
Ingram Robert Alexander
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 405----1%
38.61K to 39.02K
05-Apr-10 7:12 PM
View: 
Kugelman Larry
Director
Valeant Pharmaceuticals Int... (VRX) 01-Apr-10Grant 419----1%
34.16K to 34.57K
18-Mar-10 7:20 PM
View: 
Blott Peter J
EVP & CFO
Valeant Pharmaceuticals Int... (VRX) 16-Mar-10Payment of Exercise 436$39.86$17,379.00(< 1%)
90.92K to 90.49K
(1%)
02-Mar-10 3:10 PM
View: 
Stefano Stephen F.
Director
Valeant Pharmaceuticals Int... (VRX) 01-Mar-10Market Purchase 3,300$37.28$123,024.0025%
13.39K to 16.69K
2%
03-Feb-10 3:18 PM
View: 
Pearson J. Michael
CEO and Chairman of the Board
Director
Valeant Pharmaceuticals Int... (VRX) 01-Feb-10Payment of Exercise 31,840$33.72$1,073,640.00(3%)
1.04M to 1.0M
(3%)
22-Jan-10 2:21 PM
View: 
de Silva Rajiv
Chief Operating Officer
Valeant Pharmaceuticals Int... (VRX) 21-Jan-10Payment of Exercise 2,143$34.27$73,440.60(2%)
98.63K to 96.49K
0%
05-Jan-10 5:56 PM
View: 
Lonner Anders
Director
Valeant Pharmaceuticals Int... (VRX) 04-Jan-10Grant 512----6%
8.88K to 9.39K
05-Jan-10 5:55 PM
View: 
Ingram Robert Alexander
Director
Valeant Pharmaceuticals Int... (VRX) 04-Jan-10Grant 512----1%
37.97K to 38.48K
05-Jan-10 5:56 PM
View: 
Kugelman Larry
Director
Valeant Pharmaceuticals Int... (VRX) 04-Jan-10Grant 571----2%
33.58K to 34.16K